LEO Pharma Unveils Anzupgo® (delgocitinib) Cream Results at EADV 2024 for Chronic Hand Eczema
LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data from the DELTA FORCE trial at the 33rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam. The company shared six additional abstracts regarding Anzupgo® (delgocitinib)…
Perosphere Technologies to Present on Point-of-Care Coagulometer at ADLM CPOCT Symposium
Perosphere Technologies Inc., a private medical tech company specializing in next-generation coagulation diagnostics, announced its participation in the 29th ADLM International Critical & Point of Care Testing (CPOCT) Symposium, held September 25-27, 2024, in San Diego, CA. Perosphere CEO Dr.…
Oneview Healthcare Partners with Children’s Hospital of Orange County
Oneview Healthcare, a global leader in healthcare technology, has signed an agreement with Children’s Hospital of Orange County (CHOC). This partnership marks the first commercial adoption of Oneview’s new product, MyStay Mobile, solidifying the company’s role as a preferred partner…
C2N Secures Funding to Develop Decentralized Mass Spectrometry for Global Alzheimer’s Testing
C2N Diagnostics, a global leader in Alzheimer’s diagnostics with its Precivity blood tests, plans to develop a fully automated and standardized high-resolution LC-MS platform. This technology will allow local clinical labs worldwide to utilize the precise innovation behind C2N’s clinical…
Almirall Showcases New Biologics Data for Psoriasis and Atopic Dermatitis at EADV Congress, Celebrating 80 Years of Innovation
Almirall, S.A. (ALM), a global leader in medical dermatology, will participate in the 33rd Congress of the European Academy of Dermatology and Venereology (EADV) in Amsterdam from September 25 to 28, 2024. This year also marks Almirall’s 80th anniversary, celebrating…
Funding Boosts Neuranics’ AI for Remote Heart Health Monitoring
Maja Schmidt, in partnership with Neuranics Limited and the University of Edinburgh, has received the prestigious Royal Commission for the Exhibition of 1851 Industrial Fellowship for her groundbreaking AI-based project on remote heart health monitoring. This initiative seeks to improve…
ImageBloom Launches First-of-Its-Kind Patient Recruitment Marketplace for Clinical Research
ImageBloom, Inc., a leader in clinical trial support solutions, is thrilled to announce the launch of the Patient Recruitment Marketplace. This groundbreaking platform is set to transform patient recruitment for clinical research sites. It allows research teams to quickly access…
True You Weight Loss Becomes First U.S. Practice to Perform 5,000 Endoscopic Weight Loss Procedures
Gastroenterologist and obesity medicine specialist Dr. Christopher McGowan performed the 5,000th endobariatric weight loss procedure this week at True You Weight Loss, marking the practice as the first in the nation to achieve this notable milestone. Endobariatrics: A New Approach…
Aditxt’s Pearsanta Partners with Evofem for U.S. Endometriosis Diagnostic Launch in Mid-2025
Aditxt, Inc. (NASDAQ: ADTX), an innovation platform aimed at accelerating health advancements, has announced that its majority-owned subsidiary, Pearsanta, Inc., has entered into a Market Development Collaboration Agreement with Evofem Biosciences, a leader in women’s health. This partnership will focus…
Debiopharm Honors Innovative Japanese Cancer Research at 83rd Japanese Cancer Association Meeting
Debiopharm Honors Recipients of 2024 JCA-Mauvernay Award for Breakthrough Cancer Research Debiopharm, a Swiss-based biopharmaceutical company focused on advancing cancer and infectious disease treatments, has announced the winners of the 2024 JCA-Mauvernay Award, celebrating its 20th edition. The award recognizes…
Tandem tX2 Pump Now Compatible with Lyumjev Insulin in EU
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leader in insulin delivery and diabetes technology, has announced that its t:slim X2 insulin pump, equipped with Control-IQ automated insulin delivery technology, is now approved for use with Eli Lilly’s Lyumjev® (insulin lispro-aabc…
AngioDynamics Launches RECOVER-AV Trial for AlphaVac F18⁸⁵ System in Pulmonary Embolism Treatment
AngioDynamics, Inc. (NASDAQ: ANGO), a leading medical technology company dedicated to enhancing vascular health and expanding cancer treatment options, has announced the launch of the RECOVER-AV trial. This prospective, multicenter, multinational, single-arm study will evaluate the efficacy, safety, and long-term…